Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-03

Clinical Trial Update: Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Cardiac Neuromodulation Therapy washout sub-study (Phase 1/Phase 2) by BackBeat Medical; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cardiac Neuromodulation Therapy (CNT) (Cardiac neuromodulation therapy)

Snippet

Sponsor: BackBeat Medical Inc | Conditions: Hypertension,Essential, Systolic Hypertension | Phase 1, Phase 2 | Status: UNKNOWN